Your browser doesn't support javascript.
loading
The clinical utility and safety of short-course immune checkpoint inhibitors in multiple tumours-A real-world multicentric study from India.
Abraham, George; Noronha, Vanita; Rajappa, Senthil; Agarwal, Amit; Batra, Ullas; Somani, Naresh; Raja, Thirumalairaj; Patil, Shekhar; Kaushal, Ashish M; Joshi, Ashish; Radhakrishnan, Vivek; Singh, Navneet; Babu, Govind; Tewani, Rohan; Baghmar, Saphalta; Dodagoudar, Chandragouda; Ananthakrishnan, Ramya; Haragadde Poppareddy, Shashidhara; Sharma, Vibhor; Menon, Nandini; M Patil, Vijay; Joshi, Amit; Gupta, Sudeep; Prabhash, Kumar; Bajpai, Jyoti.
Afiliação
  • Abraham G; Department of Medical Oncology, Tata Memorial Centre, Mumbai, India.
  • Noronha V; Department of Medical Oncology, Tata Memorial Centre, Mumbai, India.
  • Rajappa S; Department of Medical Oncology, Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, India.
  • Agarwal A; Department of Medical Oncology, BLK Superspeciality Hospital, Delhi, India.
  • Batra U; Department of Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India.
  • Somani N; Department of Medical Oncology, HCG Cancer Centre, Jaipur, India.
  • Raja T; Department of Medical Oncology, Apollo Hospitals, Chennai, India.
  • Patil S; Department of Medical Oncology, HCG Cancer Centre, Bengaluru, India.
  • Kaushal AM; Department of Medical Oncology, HCG Cancer Centre, Ahmedabad, India.
  • Joshi A; Department of Medical Oncology, Mumbai Oncocare Centre, Mumbai, India.
  • Radhakrishnan V; Department of Medical Oncology, Tata Medical Center, Kolkata, India.
  • Singh N; Department of Medical Oncology, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
  • Babu G; Department of Medical Oncology, Kidwai Memorial Institute of Oncology, Bengaluru, India.
  • Tewani R; Department of Medical Oncology, Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, India.
  • Baghmar S; Department of Medical Oncology, BLK Superspeciality Hospital, Delhi, India.
  • Dodagoudar C; Department of Medical Oncology, BLK Superspeciality Hospital, Delhi, India.
  • Ananthakrishnan R; Department of Medical Oncology, Apollo Hospitals, Chennai, India.
  • Haragadde Poppareddy S; Department of Medical Oncology, HCG Cancer Centre, Bengaluru, India.
  • Sharma V; Department of Medical Oncology, Paras Hospitals, Gurgaon, India.
  • Menon N; Department of Medical Oncology, Tata Memorial Centre, Mumbai, India.
  • M Patil V; Department of Medical Oncology, Tata Memorial Centre, Mumbai, India.
  • Joshi A; Department of Medical Oncology, Tata Memorial Centre, Mumbai, India.
  • Gupta S; Department of Medical Oncology, Tata Memorial Centre, Mumbai, India.
  • Prabhash K; Department of Medical Oncology, Tata Memorial Centre, Mumbai, India.
  • Bajpai J; Department of Medical Oncology, Tata Memorial Centre, Mumbai, India.
Int J Cancer ; 150(6): 1045-1052, 2022 03 15.
Article em En | MEDLINE | ID: mdl-34751432

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 6_other_respiratory_diseases / 6_trachea_bronchus_lung_cancer Assunto principal: Inibidores de Checkpoint Imunológico / Neoplasias Tipo de estudo: Clinical_trials / Observational_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Índia

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 6_other_respiratory_diseases / 6_trachea_bronchus_lung_cancer Assunto principal: Inibidores de Checkpoint Imunológico / Neoplasias Tipo de estudo: Clinical_trials / Observational_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Int J Cancer Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Índia
...